Dashboard
Manage Tickers

ZURAZura Bio Ltd

Nasdaq zurabio.com


$ 5.19 $ 0.03 (0.58 %)    

Wednesday, 15-May-2024 15:59:41 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 5.19
$ 5.03
$ 0.00 x 0
$ 0.00 x 0
$ 4.99 - $ 5.25
$ 2.00 - $ 13.00
128,038
na
62.28M
$ 0.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-28-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 04-11-2022 12-31-2021 10-K
11 11-19-2021 09-30-2021 10-Q
12 08-27-2021 03-31-2021 10-Q
13 08-27-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

oppenheimer-maintains-outperform-on-zura-bio-raises-price-target-to-21
Oppenheimer Maintains Outperform on Zura B...
05/10/2024 16:48:54

Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and raises the price target from $16 to $21.

zura-bio-q1-2024-gaap-eps-002-beats-023-estimate
Zura Bio Q1 2024 GAAP EPS $(0.02) Beats $(...
05/09/2024 10:16:30

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.23) by 9...

piper-sandler-initiates-coverage-on-zura-bio-with-overweight-rating-announces-price-target-of-26
Piper Sandler Initiates Coverage On Zura B...
05/03/2024 09:36:15

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Zura Bio (NASDAQ:ZURA) with a Overweight rating and announces Pri...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
04/26/2024 16:31:22

zura-bio-announces-oversubscribed-1125m-private-placement-for-201m-class-a-shares-at-a-price-of--3108-per-share-financing-includes-new-and-existing-leading-life-sciences-institutional-investors-strengthened-balance-sheet-expected-to-fund-operations-through-2027
Zura Bio Announces Oversubscribed $112.5M ...
04/18/2024 13:23:45

- Financing includes new and existing leading life sciences institutional investors- Strengthened balance sheet expected to fun...

zura-bio-announces-that-robert-lisicki-has-assumed-the-role-of-chief-executive-officer-and-a-director
Zura Bio Announces That Robert Lisicki Has...
04/08/2024 10:11:02

Succeeds Founding CEO, Dr. Someit Sidhu, who will continue as a Board Director Recognized as inspirational industry leader w...

oppenheimer-reiterates-outperform-on-zura-bio-lowers-price-target-to-16
Oppenheimer Reiterates Outperform on Zura ...
04/01/2024 13:33:49

Oppenheimer analyst Jeff Jones reiterates Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $17 to $16.

zura-bio-q4-eps-030-misses-023-estimate
Zura Bio Q4 EPS $(0.30) Misses $(0.23) Est...
03/28/2024 12:22:44

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.23) by...

zura-bio-has-appointed-robert-lisicki-as-ceo-effective-april-8-2024-succeeding-someit-sidhu-who-remains-actively-involved-in-the-company-as-a-non-independent-director-of-the-board
Zura Bio Has Appointed Robert Lisicki As C...
03/28/2024 10:26:37

zura-bio-fy23-eps-209-beats-299-estimate-cash-position-of-998m-expected-to-provide-cash-runway-into-into-2026
Zura Bio FY23 EPS $(2.09) Beats $(2.99) Es...
03/28/2024 10:19:56

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/22/2024 17:31:17

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
12/18/2023 21:31:50

zura-bio-announced-two-abstracts-were-presented-at-world-allergy-congress-highlighting-zb-168-an-anti-il-7r-monoclonal-antibody-and-zb-880-torudokimab-monoclonal-antibody-that-neutralizes-il-33
Zura Bio Announced Two Abstracts Were Pres...
12/04/2023 11:04:59

zura-bio-q4-eps-018-beats-025-estimate-cash-position-of-1039m-in-cash-cash-equivalents-and-investments-is-expected-to-support-development-and-operations-into-2026
Zura Bio Q4 EPS $(0.18) Beats $(0.25) Esti...
11/13/2023 11:32:47

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.25) by 2...

benzingas-top-ratings-upgrades-downgrades-for-october-10-2023
Benzinga's Top Ratings Upgrades, Downgrade...
10/10/2023 15:00:33

ladenburg-thalmann-initiates-coverage-on-zura-bio-with-buy-rating-announces-price-target-of-10
Ladenburg Thalmann Initiates Coverage On Z...
10/10/2023 12:56:38

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Zura Bio (NASDAQ:ZURA) with a Buy rating and announces Price...

zura-bio-enters-into-sponsored-research-agreement-with-benaroya-research-institute-terms-undisclosed
Zura Bio Enters into Sponsored Research Ag...
09/12/2023 09:01:45

Zura Bio Limited (NASDAQ:ZURA) ("Zura Bio"), a multi-asset clinical-stage biotechnology company focused on developing n...

benzingas-top-ratings-upgrades-downgrades-for-august-25-2023
Benzinga's Top Ratings Upgrades, Downgrade...
08/25/2023 15:00:24

oppenheimer-initiates-coverage-on-zura-bio-with-outperform-rating-announces-price-target-of-17
Oppenheimer Initiates Coverage On Zura Bio...
08/25/2023 07:07:01

Oppenheimer analyst Justin Kim initiates coverage on Zura Bio (NASDAQ:ZURA) with a Outperform rating and announces Price Tar...

where-zura-bio-stands-with-analysts
Where Zura Bio Stands With Analysts
08/15/2023 19:00:38

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION